Linked Life Data

19214027

Source:http://linkedlifedata.com/resource/pubmed/id/19214027

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-2-13
pubmed:abstractText
Left ventricular hypertrophy (LVH) is a common cardiovascular disorder and an independent risk factor for cardiovascular death in dialysis patients. Hyperphosphatemia is associated with LVH. Previous studies have shown that fibroblast growth factor 23 (FGF23), which has an important role in phosphate metabolism, is elevated in chronic hemodialysis patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0002-9629
pubmed:author
pubmed:issnType
Print
pubmed:volume
337
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
116-22
pubmed:meshHeading
pubmed-meshheading:19214027-Adolescent, pubmed-meshheading:19214027-Adult, pubmed-meshheading:19214027-Aged, pubmed-meshheading:19214027-Aged, 80 and over, pubmed-meshheading:19214027-Cohort Studies, pubmed-meshheading:19214027-Echocardiography, pubmed-meshheading:19214027-Female, pubmed-meshheading:19214027-Fibroblast Growth Factors, pubmed-meshheading:19214027-Humans, pubmed-meshheading:19214027-Hypertrophy, Left Ventricular, pubmed-meshheading:19214027-Kidney Failure, Chronic, pubmed-meshheading:19214027-Male, pubmed-meshheading:19214027-Middle Aged, pubmed-meshheading:19214027-Prognosis, pubmed-meshheading:19214027-Proportional Hazards Models, pubmed-meshheading:19214027-Prospective Studies, pubmed-meshheading:19214027-Renal Dialysis, pubmed-meshheading:19214027-Risk Factors, pubmed-meshheading:19214027-Young Adult
pubmed:year
2009
pubmed:articleTitle
Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients.
pubmed:affiliation
School of Medicine, Chang Gung University, and Department of Nephrology, Chang Gung Memorial Hospital, Keelung, Taiwan.
pubmed:publicationType
Journal Article